NEXGEL INC - COMMON STOCK
2.5900
09-May-25 16:45:00
15 minutes delayed
Stocks
-0.0150
-0.58%
Today's range
2.5100 - 2.7000
ISIN
N/A
Source
NASDAQ
-
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd
26 Sep 2023 09:49:30 By Nasdaq GlobeNewswire
-
14 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
NEXGEL to Report Second Quarter 2023 Financial Results on August 14th
02 Aug 2023 09:00:00 By Nasdaq GlobeNewswire
-
19 Jul 2023 09:10:00 By Nasdaq GlobeNewswire
-
NEXGEL to Participate in Maxim Group’s Virtual Healthcare Conference on June 20th
15 Jun 2023 09:00:01 By Nasdaq GlobeNewswire
-
NEXGEL to Participate in the LD Micro Invitational XIII on June 6th
24 May 2023 09:00:01 By Nasdaq GlobeNewswire
-
NEXGEL Reports First Quarter 2023 Financial Results
15 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
NEXGEL to Report First Quarter 2023 Financial Results on May 15th
09 May 2023 09:15:00 By Nasdaq GlobeNewswire
-
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
27 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
15 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
07 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
08 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
NEXGEL Reports Third Quarter 2022 Financial Results
08 Nov 2022 16:11:42 By Nasdaq GlobeNewswire
-
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
02 Nov 2022 09:00:01 By Nasdaq GlobeNewswire
-
25 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
NEXGEL Develops New Hydrogel Patch to Treat Amblyopia
20 Oct 2022 08:00:03 By Nasdaq GlobeNewswire
-
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
04 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
03 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
29 Sep 2022 07:30:00 By Nasdaq GlobeNewswire